JPRN-UMIN000009675已完成未知
Pilot study of index and safety of switching to Denosumab from Zoledronic acid for hepatocellular carcinoma with bone metastasis. - Pilot study of Denosumab from Zoledronic acid for hepatocellular carcinoma with bone metastasis.
Department of Gastroenterology and Metabolism,Hiroshima University Hospital0 个研究点目标入组 35 人开始时间: 2012年12月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) CCr < 30 2) A pregnant woman, or a woman suspected of pregnancy. 10) Any condition that is unstable or could jeopardize the safety of the patient and its compliance in the study, in the investigator's judgment. 3) With odontogenic infection. 4) Patients participating in other clinical trial. 5) Any condition that is unstable or could jeopardize the safety of the patient and its compliance in the study, in the investigator's judgment.
研究者
相似试验
进行中（未招募）
不适用
Assessing the Safety and Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% Fixed Combination), as Replacement Therapy in Patients Uncontrolled on Bimatoprost 0.03%/Timolol 0.5% Therapy (Fixed or Unfixed)EUCTR2010-021973-35-CZAlcon Research, Ltd.100
进行中（未招募）
不适用
Assessing the Safety and Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% Fixed Combination), as Replacement Therapy in Patients Uncontrolled on Bimatoprost 0.03%/Timolol 0.5% Therapy (Fixed or Unfixed)Open-angle glaucoma, ocular hypertension or pigment dispersion glaucomaMedDRA version: 12.1Level: LLTClassification code 10030856Term: Open-angle glaucomaMedDRA version: 12.1Level: LLTClassification code 10030043Term: Ocular hypertensionMedDRA version: 12.1Level: LLTClassification code 10052134Term: Pigment dispersion syndromeEUCTR2010-021973-35-DEAlcon Research, Ltd.100
尚未招募
Unknown
Study of the effectiveness and safety of switching from JAK inhibitors to non-TNF biologics in elderly patients with rheumatoid arthritisRheumatoid arthritisJPRN-UMIN000050387Kawasaki Medical School30
进行中（未招募）
1 期
Assessing the safety and efficacy of switching to Azarga (Brinzolamide/Timolol Fixed Combination), as replacement therapy in patients with uncontrolled intraocular pressure - not applicableEUCTR2009-015795-10-SIAlcon d.o.o.120
已完成
不适用
Investigation of efficacy and safety of switching from basal-bolus therapy to combination therapy with GLP-1 receptor agonist and basal insulin injection in type 2 diabetestype 2 diabetesJPRN-UMIN000013222Juntendo University Graduate School of Medicine30